Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-8491
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis ; day:29 ; month:12 ; year:2022 ; pages:1-12
European archives of psychiatry and clinical neuroscience ; (29.12.2022), 1-12
- Creator
-
Kuzo, Nazar
Haen, Ekkehard
Ho, Dominic M.
Takeuchi, Hiroyoshi
Piras, Marianna
Eap, Chin B.
de Filippis, Renato
Homan, Philipp
Kane, John M.
Roy, Marc-André
Paulzen, Michael
Schoretsanitēs, Geōrgios
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00406-022-01542-1
- URN
-
urn:nbn:de:101:1-2023031021274038482531
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kuzo, Nazar
- Haen, Ekkehard
- Ho, Dominic M.
- Takeuchi, Hiroyoshi
- Piras, Marianna
- Eap, Chin B.
- de Filippis, Renato
- Homan, Philipp
- Kane, John M.
- Roy, Marc-André
- Paulzen, Michael
- Schoretsanitēs, Geōrgios
- SpringerLink (Online service)
Other Objects (12)
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study
Impact of once-daily versus multiple-daily dosing of gentamicin on the incidence of acute kidney injury in patients treated with synergistic combinations of antibiotics
Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing
Relativistic two-center continuum
Clozapine-induced agranulocytosis
Delayed bottom-up and amended simple method of dosing with once-daily tacrolimus application to achieve stable trough levels in liver transplantation
Switching to nevirapine-based HAART in virologically-suppressed patients: influence of a longer twice-daily induction period on once-a-day dosing
Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study
Impact of once-daily versus multiple-daily dosing of gentamicin on the incidence of acute kidney injury in patients treated with synergistic combinations of antibiotics
Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing
Relativistic two-center continuum
Clozapine-induced agranulocytosis
Delayed bottom-up and amended simple method of dosing with once-daily tacrolimus application to achieve stable trough levels in liver transplantation
Switching to nevirapine-based HAART in virologically-suppressed patients: influence of a longer twice-daily induction period on once-a-day dosing
Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study
Impact of once-daily versus multiple-daily dosing of gentamicin on the incidence of acute kidney injury in patients treated with synergistic combinations of antibiotics
Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing
Relativistic two-center continuum
Clozapine-induced agranulocytosis
Delayed bottom-up and amended simple method of dosing with once-daily tacrolimus application to achieve stable trough levels in liver transplantation
Switching to nevirapine-based HAART in virologically-suppressed patients: influence of a longer twice-daily induction period on once-a-day dosing